LABCORP HOLDINGS INC (LH) Stock News
NYSE:LH - New York Stock Exchange, Inc. - US5049221055 - Common Stock
LH Latest News and Analysis
Interesting LH Put And Call Options For March 21st
Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a...
LABCORP DECLARES QUARTERLY DIVIDEND
/PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of...
Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025
/PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for...
Jim Cramer Says Lazard Is 'Really Inexpensive,' Recommends Buying This Tech Stock
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the commercial availability of its new...
Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients
/PRNewswire/ -- Outcomes4Me Inc., the developer of the first and only end-to-end, actionable cancer platform, announced today it has been selected to present...
Labcorp CFO Glenn Eisenberg Announces Plans to Retire
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that Executive Vice President and...
LH January 2025 Options Begin Trading
Labcorp Announces 2024 Third Quarter Results
Updates Full-Year Guidance Results from Continuing Operations for third quarter 2024 versus last year: Revenue: $3.28 billion versus $3.06 billion Diluted EPS:...
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it has expanded its portfolio of...
Labcorp Declares Quarterly Dividend
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has...
Labcorp to Announce Third Quarter Financial Results on October 24, 2024
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third...
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience
/PRNewswire/ -- Ovia Health by Labcorp (Ovia) today announced the expansion of its women's health solutions to include a personalized, comprehensive Postpartum...
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034
/PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH) (Labcorp) announced today that its wholly owned subsidiary, Laboratory Corporation of America Holdings (LCAH),...
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational...
Labcorp to Speak at the Baird 2024 Global Healthcare Conference
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive...
Labcorp Finalizes Acquisition of Select Assets of Invitae
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of...
Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it has received De Novo marketing...
Labcorp Announces 2024 Second Quarter Results
Updates Full-Year Guidance Results from Continuing Operations for second quarter 2024 versus last year: Revenue: $3.22 billion versus $3.03 billion Diluted...
Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with Ultima...
Is This Telehealth Stock a Buy After the Recent Pullback?
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.